Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1245/s10434-023-13910-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
J Exp Clin Cancer Res
January 2025
Department of Pharmacology, School of Pharmacy, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning Province, 110122, P. R. China.
The excision of introns from pre-mRNA is a crucial process in the expression of the majority of genes. Alternative splicing allows a single gene to generate diverse mRNA and protein products. Aberrant RNA splicing is recognized as a molecular characteristic present in almost all types of tumors.
View Article and Find Full Text PDFASO Author Reflections: Tackling the Unresolved Topic: Impact of Adjuvant Chemotherapy on Survival in Patients with Surgically Treated Uterine Cervical Cancer.
Ann Surg Oncol
January 2025
Department of Obstetrics and Gynecology, Osaka Rosai Hospital, Sakai, Osaka, Japan.
A biomass-based "double-encapsulation structure" heightens the flame retardancy, antimicrobial effectiveness, and hydrophobicity of cotton fabric.
Int J Biol Macromol
January 2025
College of Textile and Clothing, Institute of Functional Textiles and Advanced Materials, State Key Laboratory of Bio-fibers and Eco-textiles, Qingdao University, Qingdao 266071, China. Electronic address:
Due to the non-renewable nature of petroleum resources, there has been a notable shift toward utilizing biomass materials to confer flame retardant properties to cotton fabrics. However, endow solely with single function cannot meet the application requirements across various fields. Therefore, there is considerable impetus to develop multifunctional cotton fabrics integrating flame retardant, antimicrobial, and hydrophobic properties sourced from biomass.
View Article and Find Full Text PDFProgress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy.
J Muscle Res Cell Motil
January 2025
Institute of Developmental and Regenerative Medicine, University of Oxford, IMS-Tetsuya Nakamura Building, Old Road Campus, Roosevelt Dr, Headington, Oxford, OX3 7TY, UK.
Recent years have seen enormous progress in the field of advanced therapeutics for the progressive muscle wasting disease Duchenne muscular dystrophy (DMD). In particular, four antisense oligonucleotide (ASO) therapies targeting various DMD-causing mutations have achieved FDA approval, marking major milestones in the treatment of this disease. These compounds are designed to induce alternative splicing events that restore the translation reading frame of the dystrophin gene, leading to the generation of internally-deleted, but mostly functional, pseudodystrophin proteins with the potential to compensate for the genetic loss of dystrophin.
View Article and Find Full Text PDFASO Visual Abstract: The Impact of Perioperative Radiotherapy on Disease-Specific Survival in Patients with Localized Retroperitoneal Liposarcoma-A Population-Based Propensity-Score Matched Analysis.
Ann Surg Oncol
January 2025
Department of Surgery, Clarunis St. Clara Hospital & University Hospital Basel, Basel, Switzerland.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!